Primary Site >> Stomach Cancer

Gene >> THRA

Journal: Oncogene. 1988 Mar;2(3):283-7.
Title: Genetic alterations of the c-erbB-2 oncogene occur frequently in tubular adenocarcinoma of the stomach and are often accompanied by amplification of the v-erbA homologue.
Author: Yokota, J|Yamamoto, T|Miyajima, N|Toyoshima, K|Nomura, N|Sakamoto, H|Yoshida, T|Terada, M|Sugimura, T
PMID: 3281095
Journal: Princess Takamatsu Symp. 1989;20:43-8.
Title: Multiple genetic alterations in small-cell lung carcinoma.
Author: Yokota, J|Mori, N|Akiyama, T|Shimosato, Y|Sugimura, T|Terada, M
PMID: 2577337
Journal: J Clin Oncol. 1991 May;9(5):827-31.
Title: Sequential high-dose methotrexate and fluorouracil combined with doxorubicin--a step ahead in the treatment of advanced gastric cancer: a trial of the European Organization for Research and Treatment of Cancer Gastrointestinal Tract Cooperative Group.
Author: Wils, J A|Klein, H O|Wagener, D J|Bleiberg, H|Reis, H|Korsten, F|Conroy, T|Fickers, M|Leyvraz, S|Buyse, M
PMID: 2016625
Journal: Front Pharmacol. 2018 Aug 3;9:861.
Title: Cross-Database Analysis Reveals Sensitive Biomarkers for Combined Therapy for ERBB2+ Gastric Cancer.
Author: Xiang, Zhen|Huang, Xia|Wang, Jiexuan|Zhang, Jun|Ji, Jun|Yan, Ranlin|Zhu, Zhenggang|Cai, Wei|Yu, Yingyan
PMID: 30123134